Sam Michael
National Institutes of Health · 155 works · 5,856 citations · h-index 35
Top works
- The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
- Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
- High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
- The Tox21 robotic platform for the assessment of environmental chemicals – from vision to reality
- Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
- A Robotic Platform for Quantitative High-Throughput Screening
- Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
- Compound Management for Quantitative High-Throughput Screening
- Profiling of the Tox21 Chemical Collection for Mitochondrial Function to Identify Compounds that Acutely Decrease Mitochondrial Membrane Potential
- Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
- Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition
- Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
- High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
- A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells
- Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
- The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
- Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research
- Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
- Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
- Quantitative High-Throughput Screening Using a Live-Cell cAMP Assay Identifies Small-Molecule Agonists of the TSH Receptor